Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Peijia Medical Ltd. ( (HK:9996) ) has shared an update.
Peijia Medical Ltd. announced that all resolutions proposed at its Annual General Meeting on May 27, 2025, were passed. These resolutions included the adoption of financial statements, re-election of directors, appointment of auditors, and granting of mandates to the board for share issuance and repurchase. The successful passage of these resolutions supports the company’s governance and operational strategies, potentially strengthening its market position and reassuring stakeholders of its stable management.
The most recent analyst rating on (HK:9996) stock is a Buy with a HK$4.00 price target. To see the full list of analyst forecasts on Peijia Medical Ltd. stock, see the HK:9996 Stock Forecast page.
More about Peijia Medical Ltd.
Peijia Medical Ltd. is a company incorporated in the Cayman Islands, operating in the medical industry. It focuses on developing and providing medical devices, particularly in the field of cardiovascular and neurovascular diseases.
Average Trading Volume: 1,813,865
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.87B
For a thorough assessment of 9996 stock, go to TipRanks’ Stock Analysis page.